Relapse of Experimental Autoimmune Encephalomyelitis after Discontinuation of FTY720 (Fingolimod) Treatment, but Not after Combination of FTY720 and Pathogenic Autoantigen-Reference-Cited by-同舟云学术

Relapse of Experimental Autoimmune Encephalomyelitis after Discontinuation of FTY720 (Fingolimod) Treatment, but Not after Combination of FTY720 and Pathogenic Autoantigen

Published:2011 Issue:6 Volume:34 Page:933-936
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Yoshida Yuya¹,Tsuji Takumi¹,Fujita Tetsuro²,Kohno Takeyuki¹²

Affiliation:

1. Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Setsunan University

2. Research Institute for Production and Development

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

http://www.jstage.jst.go.jp/article/bpb/34/6/34_6_933/_pdf

Reference23 articles.

1. Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite.

2. Synthesis and Immunosuppressive Activity of 2-Substituted 2-Aminopropane-1,3-diols and 2-Aminoethanols

3. Synthesis of the Key Intermediate, Diethyl 2-Acetylamino-2-(2-(4-octanoylphenyl)ethyl)propane-1,3-dioate, of the Immunomodulatory Agent FTY720 (Fingolimod)

4. 4) Brinkmann V., Pinschewer D., Chiba K., Feng L., Trends Pharmacol. Sci., 21, 49—52 (2000).

5. Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple faces of multiple sclerosis in the era of highly efficient treatment modalities: Lymphopenia and switching treatment options challenges daily practice;International Immunopharmacology;2023-12

2. Synthesis and Comprehensive in Vivo Activity Profiling of Olean-12-en-28-ol, 3β-Pentacosanoate in Experimental Autoimmune Encephalomyelitis: A Natural Remyelinating and Anti-Inflammatory Agent;Journal of Natural Products;2023-01-04

3. Sivelestat's effect on Candida albicans water‐soluble fraction‐induced vasculitis;Pediatrics International;2022-01

4. Abuse and dependence potential of sphingosine-1-phosphate (S1P) receptor modulators used in the treatment of multiple sclerosis: a review of literature and public data;Psychopharmacology;2021-11-13

5. Severe disease exacerbations in patients with multiple sclerosis after discontinuing fingolimod;Neurologia i Neurochirurgia Polska;2017-03